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Sir,
Continued high prevalence in cardiac morbidity in
the US has led to more refractive surgical candi-
dates with cardiac implantable electronic devices
(CIED), although the Food and Drug Adminis-
tration (FDA) studies have consistently excluded
such populations during laser-assisted in situ ker-
atomileusis (LASIK) or photorefractive keratectomy
(PRK) evaluations. Major manufacturers have dis-
couraged laser eye surgery in patients with CIEDs
until recently when Medtronic and St. Jude, the two
largest manufacturers of such devices, approved
LASIK surgery with recommendations to shielding
the CIED with a magnet and closely monitoring the
heart rate during the surgery.[1] We aim to share our
insights and experiences over the years, hopefully
mitigating some of the concerns in clinical practice.
The excimer laser can electromagnetically inter-
fere with the CIEDs and cause changes in a
surgical setting[2] with potential adverse effects
including cardiac stimulation inducing ventricular
tachycardia or ventricular fibrillation, unexpected
movement of the body, and interference with the
ability of the CIEDs to adequately monitor for
potential arrhythmias.[3] The factors affecting elec-
tromagnetic interference depend on the frequency
of the emitting device, the distance between
the devices, and the amount of shielding of the
affected device.[2] Particularly, with excimer use,
L’Esperance et al[4] demonstrated that nearly all
of the 193 nm energy is absorbed by the cornea
indicating that the frequency of light emitted by
the ablation process may not cause significant
interference with the CIEDs. Furthermore, a recent
study by Sher et al[5] demonstrated that in-vitro
operation with the three most commonly used
ophthalmic lasers (VISX Star S4 Excimer Laser,
Lumenis Selecta II Glaucoma Laser, and Laserex
Ultra Q Photodisruptor) did not lead to oversens-
ing, inappropriate therapy, or change in the pro-
gramming of the Atlas II+ implantable cardioverter
defibrillators (ICDs) or the St. Jude Medical Victory
pacemaker.
We retrospectively analyzed data from 1997 to
2014, and found at least 13 patients documented
with a CIED, although we expect more patients
with such a device who did not disclose this
information to us, necessitating the surgeon to ask
this important question to all refractive surgery
candidates. The average age of patients under-
going LASIK/PRK correction in our center was
approximately 35 years (range: 23–60), and in
this cohort was 52 years (range: 27–77) with a
male predominance (69%) – a consistent finding
in individuals with arrhythmia or heart disease.
The indications of CIED were primarily for atrial
fibrillation (46%), although one male patient aged
27 years had the device for Wolf-Parkinson-White
syndrome. The other small subset of patients
had the device for either ventricular tachycar-
dia, atrioventricular block of unknown degree, or
an unspecified arrhythmia. Out of 13 patients,
one patient developed ventricular tachycardia two
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weeks postoperatively. However, the consulting
cardiologist felt the etiology was due to her uncon-
trolled underlying condition, rather than any elec-
tromagnetic interference from the femtosecond
and excimer laser that may have offset the device
settings. From our records, none of the other
patients experienced any CIED-related complica-
tions during the surgery. There was no clinically
detectable change in the heart rate or rhythm, and
postoperatively, the programmed parameters of
the pacemakers and/or ICDs remained unchanged.
Due to the older age, LASIK enhancement was
usually used to achieve emmetropia following the
cataract surgery. Thus, we believe this information
may be particularly helpful to those clinicians who
tend to perform LASIK on the elderly population in
their practice.
Each laser and CIED has a unique design and
may interfere with one another differently. The
current body of evidence and our concomitant
experiences illustrate a low risk of complications
in patients with CIED during refractive surgery. We
believe it is safest to inactivate any anti-tachycardia
functions if electrocautery is used during surgery[3]
and to follow manufacturer recommendations at
all times. With the recent paradigm shift in the
advancements to leadless pacemakers, some of
these newer devices are immune to electromag-
netic interference up to a very high threshold.[5]
These remarkable technological advancements
will only make ophthalmic lasers safer for patients
with CIEDs in the future.
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